SCHEMBL30079320

SCHEMBL30079320

CC(C)(C)OC(=O)N[C@@H]1CCN(c2c(F)cccc2C=O)C1

nearest known ligand 0.52

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ PIM1 P11309 1/20 0.52
▸ PIM3 Q86V86 1/20 0.52
▸ PIM2 Q9P1W9 1/20 0.52
▸ CTSK P43235 2/20 0.44
▸ CKS1B P61024 1/20 0.43
▸ SKP1 P63208 1/20 0.43
▸ SKP2 Q13309 1/20 0.43
▸ KDM4D Q6B0I6 6/20 0.43
▸ PDE10A Q9Y233 1/20 0.43
▸ MAP4K4 O95819 2/20 0.42
▸ KMT2A Q03164 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ PARP1 P09874 1/20 0.41
▸ DRD2 P14416 1/20 0.40
▸ KCNA3 P22001 1/20 0.40
▸ BRD4 O60885 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27142615 0.94 PIM1 (0.47) PIM1PIM3PIM2CTSKCKS1B
SCHEMBL27518105 0.92 PIM1 (0.52) PIM1PIM3PIM2CTSKCKS1B
SCHEMBL13537761 0.88 PIM1 (0.53) PIM1PIM3PIM2CTSKCKS1B
SCHEMBL12283785 0.88 PIM1 (0.52) PIM1PIM3PIM2CTSKCKS1B
SCHEMBL12283853 0.88 PIM1 (0.52) PIM1PIM3PIM2CTSKCKS1B
SCHEMBL12283734 0.88 PIM1 (0.52) PIM1PIM3PIM2CTSKCKS1B
SCHEMBL27591404 0.87 PIM1 (0.49) PIM1PIM3PIM2CTSKCKS1B
SCHEMBL27572723 0.87 PIM1 (0.49) PIM1PIM3PIM2CTSKCKS1B
SCHEMBL12284134 0.87 PIM1 (0.52) PIM1PIM3PIM2CTSKCKS1B
SCHEMBL30079063 0.86 PIM1 (0.48) PIM1PIM3PIM2CTSKCKS1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3737684-B1 2,4,6,7-TETRAHYDRO-PYRAZOLO[4,3-D]PYRIMIDIN-5-ONE DERIVATIVES AND RELATED COMPOUNDS AS C5A RECEPTOR MODULATORS FOR TREATING VASCULITIS AND INFLAMMATORY DISEASES IDORSIA PHARMACEUTICALS LTD (CH) 2022-11-16 — — EP disclosed
Send feedback